Biospace

Published September 16, 2026 · Updated September 17, 2026

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 ...

Read the full story at Biospace

PulseSight is a clinical-stage biotech company committed to developing ... Psychedelic therapies ride wave of public favor into FDA hearing.